Clinical Trial Update: The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis [Phase 1]

View source ↗

Summary

Phase 1 SEAPORT 1 trial evaluating the safety and tolerability of INZ-701 in adults with end-stage kidney disease on hemodialysis for calciphylaxis has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calciphylaxis

Drugs mentioned

• INZ-701

Snippet

Sponsor: Inozyme Pharma | Conditions: Calciphylaxis | Phase 1 | Status: COMPLETED